Patient-reported Quality of Life outcomes in patients treated for muscle-invasive bladder cancer with radiotherapy ± chemotherapy in the BC2001 Phase III Randomised Controlled Trial
Date
2020-02Journal
European UrologyType
Journal ArticleRandomized Controlled Trial
Publisher
ElsevierDOI
10.1016/j.eururo.2019.11.001Rights
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)Metadata
Show full item recordAbstract
BC2001, the largest randomised trial of bladder-sparing treatment for muscle-invasive bladder cancer, demonstrated improvement of local control and bladder cancer-specific survival from the addition of concomitant 5-fluorouracil and mitomycin C to radiotherapy.